| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/20/2006 | US20060084618 Adiponectin promoter and use thereof |
| 04/20/2006 | US20060084617 Methods for delivery of nucleic acids |
| 04/20/2006 | US20060084600 Human homologues of fused gene |
| 04/20/2006 | US20060084164 Bacteria, yeasts or filamentous fungi, producing a fusion protein containing a hydrophobin fused to a protein, an enzyme or part of an enzyme with enzymatic activity, wherein said hydrophobin or hydrophobin-like protein has an ability to partition in aqueous two-phase systems (ATPS) |
| 04/20/2006 | US20060084163 Plant-derived alkaline alpha-galactosidase |
| 04/20/2006 | US20060084157 Hydrogen production |
| 04/20/2006 | US20060084155 transferase for producing 4-hydroxybutyryl-Co A (4HB) containing polyhydroxyalkanoate (PHAs) from cheap carbon sources such as sugars and fatty acids |
| 04/20/2006 | US20060084149 Forming complex in which single-stranded nucleic acid is bound to a double-stranded beta -1,3-glucan which as 1,6-glucopyranoside branch and is chemically modified through periodate oxidation and reductive amination so as to impart nucleic acid-binding functional groups; for use as an antisense agent |
| 04/20/2006 | US20060084148 April-a novel protein with growth effects |
| 04/20/2006 | US20060084144 Genetic engineering; oligonucleotide detector; identification and isolation of novel DNA; transmembrane domain-deleted or transmembrane domain-inactivated protein; soluble extracellular domains; PRO polypeptide |
| 04/20/2006 | US20060084143 Screen for agonists and antagonists; treat solid tumors, vascular deficiencies; polypeptide, polynucleotide, plasmid; chemotherapeutic agents, alkylating agents, antimetabolites, vinca alkaloids, plant extracts, nitrosoureas, topoisomerase inhibitors, platinum analogs, adrenocortical suppressants |
| 04/20/2006 | US20060084142 tyrosine kinase; screening for inhibitors of PDGFRA; gastrointestinal stromal tumor (GIST) |
| 04/20/2006 | US20060084141 Biosynthetic gene cluster for the maytansinoid antitumor agent ansamitocin |
| 04/20/2006 | US20060084139 Genetic engineering; oligonucleotide detector; identification and isolation of novel DNA; transmembrane domain-deleted or transmembrane domain-inactivated protein; soluble extracellular domains; PRO polypeptide |
| 04/20/2006 | US20060084138 Genetic engineering; oligonucleotide detector; identification and isolation of novel DNA; transmembrane domain-deleted or transmembrane domain-inactivated protein; soluble extracellular domains; PRO polypeptide |
| 04/20/2006 | US20060084121 OX2 receptor homologs |
| 04/20/2006 | US20060084119 Preparing budding virus expressing mammalian transporter having transporter activity by culturing host cell infected with budding virus comprising gene encoding transporter and is recombinantly expressing transporter, expressing transporter on envelope of budding virus released from host cell, harvesting |
| 04/20/2006 | US20060084118 Lymphocytes; transcription factors; interferons; diagnosis of autoimmune disease such as lupus |
| 04/20/2006 | US20060084117 Galphaq protein variants and their use in the analysis and discovery of agonists and antagonists of chemosensory receptors |
| 04/20/2006 | US20060084111 Method for gene identification signature (GIS) analysis |
| 04/20/2006 | US20060084110 Methods to identify plant metabolites |
| 04/20/2006 | US20060084109 Regulated aptamer therapeutics |
| 04/20/2006 | US20060084099 Product identification method |
| 04/20/2006 | US20060084096 Biomarkers and expression profiles for toxicology |
| 04/20/2006 | US20060084093 Packaging cells comprising codon-optimized gagpol sequences and lacking lentiviral accessory proteins |
| 04/20/2006 | US20060084091 Methods and compositions for polypeptide engineering |
| 04/20/2006 | US20060084084 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/20/2006 | US20060084075 Program for analysis of the time-series data obtained by DNA array method, a method for analysis of the time-series data obtained by DNA array method, and a device for analysis of the time-series data obtained by DNA array method |
| 04/20/2006 | US20060084062 Nucleic acid of given sequence; recombinant vectors; use in preparation of pharmaceutical kits |
| 04/20/2006 | US20060084058 Substrates for hybridization and method of using the same |
| 04/20/2006 | US20060083780 liposomes; nucleic acid lipid particles; gene therapy; improved membrane fluidity |
| 04/20/2006 | US20060083756 Immunogens; replication-defective; antibodies; host cells; kits |
| 04/20/2006 | US20060083755 Vaccine for feline infectious peritonitis |
| 04/20/2006 | US20060083753 Fusobacterium polypeptides and methods of use |
| 04/20/2006 | US20060083752 Novel compounds |
| 04/20/2006 | US20060083746 Receptor for B. anthracis toxin |
| 04/20/2006 | US20060083740 By modulating the expression of mutant and wild type CD83 gene products produced in a mammal; regulation of T cell and dendritic cell activity; antibodies |
| 04/20/2006 | US20060083737 Intracellular peptide delivery |
| 04/20/2006 | US20060083722 Methods and compositions for cell therapy |
| 04/20/2006 | US20060083715 Interferon beta-like molecules for treatment of stroke |
| 04/20/2006 | US20060083713 Methods of using a human il-17 related polypeptide to treat disease |
| 04/20/2006 | US20060081950 Molehole embedded 3-D crossbar architecture used in electrochemical molecular memory device |
| 04/20/2006 | US20060081539 Structure and method for handling magnetic particles in biological assays |
| 04/20/2006 | US20060081474 Methods and apparatus for the location and concentration of polar analytes using an alternating electric field |
| 04/20/2006 | DE19754938B4 TGC-Verfahren zur Induktion einer zielgerichteten, somatischen Transgenität TGC method for inducing a targeted somatic transgenic |
| 04/20/2006 | DE102004050101A1 Recombined polypeptide antibody or antibody fragment binds the ED-B domain of Fibronectin |
| 04/20/2006 | DE102004047776A1 Gegen Di- und/oder Multimerisierung stabilisierte Alpha-Amylase-Varianten, Verfahren zu deren Herstellung sowie Wasch- und Reinigungsmittel mit diesen Alpha-Amylase-Variaten Against di- and / or multimerization stabilized alpha-amylase variants, process for their preparation and washing and cleaning products containing these alpha-amylase variates |
| 04/20/2006 | DE102004044374A1 Verwendung einer Genveränderung im Gen des humanen CDCA3-Proteins in der medizinischen Diagnostik und Therapie Use of a gene in the gene of the human CDCA3 protein in medical diagnostics and therapy |
| 04/20/2006 | DE10101761B4 Verwendung von isolierten homogenen Nukleinsäure-Multimeren für die nicht-virale Gentherapie oder genetische Impfung Use of isolated homogeneous nucleic acid multimers of the non-viral gene therapy or genetic vaccination |
| 04/20/2006 | DE10061634B9 Verfahren zur Bestimmung unbekannter DNS-Sequenzen in komplexen Genomen Process for the determination of unknown DNA sequences in complex genomes |
| 04/20/2006 | CA2603343A1 An insecticidal plant cyclotide with activity against homopteran insects |
| 04/20/2006 | CA2584057A1 Pyruvate dehydrogenase kinases as therapeutic targets for cancer and ischemic diseases |
| 04/20/2006 | CA2583691A1 System and method for production of antibodies in plant cell culture |
| 04/20/2006 | CA2583499A1 Plasmids coding for p185neu protein sequence variants and therapeutic uses thereof |
| 04/20/2006 | CA2583380A1 Oil and seeds with reduced saturate levels of fatty acids |
| 04/20/2006 | CA2583361A1 Gene immunization using an antigen-chaperonin fusion |
| 04/20/2006 | CA2583254A1 Targeted trans-splicing of highly abundant transcripts for in vivo production of recombinant proteins |
| 04/20/2006 | CA2583243A1 Promotion of cell migration and axon regeneration in the cns |
| 04/20/2006 | CA2583147A1 Chimeric vectors |
| 04/20/2006 | CA2583017A1 Single domain camelide anti-amyloid beta antibodies and polypeptides comprising the same for the treatment and diagnosis of degenerative neural diseases such as alzheimer's disease |
| 04/20/2006 | CA2582808A1 Methods and composition for concentrating secreted recombinant proteins |
| 04/20/2006 | CA2582423A1 Brittle stalk 2 polynucleotides, polypeptides, and uses thereof |
| 04/20/2006 | CA2582157A1 Methods and compositions for improving recombinant protein production |
| 04/20/2006 | CA2581632A1 Biodegradable cationic polymers |
| 04/20/2006 | CA2580991A1 Amylin family polypeptide-6 (afp-6) analogs and methods of making and using them |
| 04/20/2006 | CA2580884A1 Method for production of a compound in a eukaryotic cell |
| 04/20/2006 | CA2579161A1 Novel regulation protein |
| 04/20/2006 | CA2550452A1 Immortalized hepatocytes |
| 04/19/2006 | EP1647598A1 Plant gene constructs and their use |
| 04/19/2006 | EP1647597A1 Chemokine N-terminal deletion mutations |
| 04/19/2006 | EP1647596A2 Monoclonal antibody against platelet membrane glycoprotein vi |
| 04/19/2006 | EP1647595A1 Nucleic acids against viruses, in particular HIV |
| 04/19/2006 | EP1647593A1 Process for producing l-histidine with the use of bacterium belonging to enterobacteriaceae |
| 04/19/2006 | EP1647557A2 Arthropod defensins |
| 04/19/2006 | EP1647281A2 Polynucleotide vaccine formula for treating horse diseases |
| 04/19/2006 | EP1647188A2 A method of controlling fungal pathogens, and agents useful for same |
| 04/19/2006 | EP1647181A1 Method of constructing plant showing improved growtn under regulation of nitrogen |
| 04/19/2006 | EP1646869A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 04/19/2006 | EP1646723A2 Castanea sativa mill. genes codifying for allene oxide cyclase, cystatin, beta-1,3-glucanase and thaumatin-like protein and their use |
| 04/19/2006 | EP1646722A1 A method of selectively producing male or female sterile plants |
| 04/19/2006 | EP1646721A1 A method of selectively producing male or female sterile plants |
| 04/19/2006 | EP1646720A2 Antibodies against insulin-like growth factor i receptor and uses thereof |
| 04/19/2006 | EP1646719A2 Nucleotides for prevention and treatment of bacterial and fungal pathologies |
| 04/19/2006 | EP1646717A2 Subgroup b adenoviral vectors for treating disease |
| 04/19/2006 | EP1646713A2 Genes encoding carotenoid compounds |
| 04/19/2006 | EP1646684A2 Polymer encapsulation of adenoviruses |
| 04/19/2006 | EP1646657A1 Antibodies to cd44 vra and methods of use |
| 04/19/2006 | EP1646656A2 Human antibody molecules for il-13 |
| 04/19/2006 | EP1646654A1 BINDING MEMBER TOWARDS PNEUMOCOCCUS SURFACE ADHESIN A PROTEIN (PsaA) |
| 04/19/2006 | EP1646648A2 Secreted polypeptide species reduced in cardiovascular disorders |
| 04/19/2006 | EP1646395A2 Methods and compositions for regulating lymphocyte activity |
| 04/19/2006 | EP1646357A2 Pro104 antibody compositions and methods of use |
| 04/19/2006 | EP1646356A2 Assays for protease enzyme activity |
| 04/19/2006 | EP1646282A1 Genetic vaccines for cancer therapy |
| 04/19/2006 | EP1570064A4 Auxin-repressed, dormancy-associated promoter and uses thereof |
| 04/19/2006 | EP1513929A4 Hybrid vector having a cytomegalovirus enhancer and myeloproliferative sarcoma virus promoter |
| 04/19/2006 | EP1404857B1 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family |
| 04/19/2006 | EP1397384B1 Antimicrobially active peptide |
| 04/19/2006 | EP1392835A4 Expression vector using for animal cell |
| 04/19/2006 | EP1379642A4 Arrayed transfection method and uses related thereto |